A reference ontology for Semantic-based Decision Support in Healthcare
IRI: http://purl.obolibrary.org/obo/chebi/AceInhibitor
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_ACEInhibitor
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Anaesthetic
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Analgesic
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Ant_TNFalph
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Antibiotic
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Antidepressants
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Antihistamine
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Antiviral
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Anxiolytic
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_BetaBlocker
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Blood
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Blood_Vessel
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Bone
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Bone_Marrow
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Bronchus
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Central_Nervous_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Chemotherapy
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Circulatory_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Corticosteroid
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Diaphragm
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Digestive_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Diuretic
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Endocrine_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Esophagus
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Exocrine_Gland
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Eye
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Gallbladder
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Hair
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Heart
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Hematopoietic_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Immune_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Immunomodulator_Immunosuppressant
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Integumentary_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Intestine
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Joint
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Kidney
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Lacrimal_Gland
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Larynx
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Liver
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Lung
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Lymph
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Lymphatic_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Lymphnode
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_MAOI
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Muscle
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Muscular_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_NSAID
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Nail
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Nervous_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Neuroleptics
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Opioid
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Oral-Anticoagulant
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Pancreas
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Peripheral_Nervous_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#AdversePharmaceuticalProduct
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Pharynx
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Prosecretory
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_PsicoPharmaceutical
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Rectum
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Respiratory_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Salicylates
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Salivary_Gland
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Skeletal_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Skin
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Spleen
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Stomach
IRI: http://sisinflab.poliba.it/swottools/onto/sh#AdverseSystem
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Tendon
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Ureter
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Urethra
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Urinary_Bladder
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Urogenital_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Visual_System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Adverse_Windpipe
IRI: http://purl.org/sig/ont/fma/Amphiarthrosis
IRI: http://purl.obolibrary.org/obo/chebi/Anaesthetic
Substance which produces loss of feeling or sensation.
IRI: http://purl.obolibrary.org/obo/chebi/Analgesic
An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.
IRI: http://purl.obolibrary.org/obo/DOID/AnatomicalEntityDisease
A disease that manifests in a defined anatomical structure.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/AnatomicalStructure
IRI: http://purl.obolibrary.org/obo/DOID/Anemia
A hematopoietic system disease that is characterized by a decrease in the normal number of red blood cells.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Anesthetist
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/AntiTnfAlpha
A pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Antibiotic
An antibiotic is a type of antimicrobial substance active against bacteria and is the most important type of antibacterial agent for fighting bacterial infections.
IRI: http://purl.obolibrary.org/obo/chebi/Anticoagulant
An agent that prevents blood clotting.
IRI: http://purl.obolibrary.org/obo/chebi/Antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
IRI: http://purl.obolibrary.org/obo/chebi/Antihistamine
Histamine antagonists are the drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists.
IRI: http://purl.obolibrary.org/obo/chebi/AntiviralDrug
A substance used in the prophylaxis or therapy of virus diseases.
IRI: http://purl.obolibrary.org/obo/chebi/AnxiolyticDrug
Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.
IRI: http://purl.obolibrary.org/obo/DOID/BacterialInfectiousDisease
A disease by infectious agent that results_in infection, has_material_basis_in Bacteria.
IRI: http://purl.obolibrary.org/obo/chebi/BetaBlocker
An agent that binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. beta-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Blood
IRI: http://purl.obolibrary.org/obo/DOID/BloodCoagulationDisease
IRI: http://purl.org/sig/ont/fma/BloodVessel
IRI: http://purl.org/sig/ont/fma/Bone
IRI: http://purl.org/sig/ont/fma/BoneMarrow
IRI: http://purl.org/sig/ont/fma/Bronchus
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Cardiologist
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/CardiovascularSystem
IRI: http://purl.obolibrary.org/obo/DOID/CardiovascularSystemDisease
A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/CentralNervousSystem
IRI: http://purl.obolibrary.org/obo/DOID/CollagenDisease
IRI: http://purl.obolibrary.org/obo/DOID/ConnectiveTissueDisease
A musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage.
IRI: http://purl.obolibrary.org/obo/chebi/Corticosteroid
A natural or synthetic analogue of the hormones secreted by the adrenal gland.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/CytotoxicDrug
A substance used in chemotherapy for cancer.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Dermatologist
IRI: http://purl.obolibrary.org/obo/DOID/Dermatomyositis
A myositis that results_in inflammation located_in muscle or located_in skin where a skin rash is often seen prior to the onset of muscle weakness. The disease may result from either a viral infection or an autoimmune reaction.
IRI: http://purl.org/sig/ont/fma/Diaphragm
IRI: http://purl.obolibrary.org/obo/DOID/DiffuseScleroderma
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/DigestiveSystem
IRI: http://purl.obolibrary.org/obo/DOID/DigestiveSystemDisease
A disease of anatomical entity that is located_in the gastrointestinal tract.
IRI: http://purl.obolibrary.org/obo/DOID/Disease
A disease is a disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.
IRI: http://purl.obolibrary.org/obo/chebi/Diuretic
An agent that promotes the excretion of urine through its effects on kidney function.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/EndocrineSystem
IRI: http://purl.org/sig/ont/fma/Esophagus
IRI: http://purl.obolibrary.org/obo/uberon/ExocrineSystem
IRI: http://purl.org/sig/ont/fma/Eye
IRI: http://purl.obolibrary.org/obo/DOID/FemaleReproductiveSystemDisease
A reproductive system disease that impairs the ability to reproduce and is located in the uterus, vagina, cervix, ovaries or fallopian tubes.
IRI: http://purl.org/sig/ont/fma/Gallbladder
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Gastroenterologist
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/GeneralPhysician
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/GenitourinarySystem
IRI: http://purl.org/sig/ont/fma/Hair
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/HealthcareProfessional
IRI: http://purl.org/sig/ont/fma/Heart
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/HematopoieticSystem
IRI: http://purl.obolibrary.org/obo/DOID/HematopoieticSystemDisease
An immune system disease that has_material_basis_in hematopoietic cells.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/ImmuneSystem
IRI: http://purl.obolibrary.org/obo/DOID/ImmuneSystemDisease
A disease of anatomical entity that is located_in the immune system.
IRI: http://purl.obolibrary.org/obo/chebi/Immunomodulator
Biologically active substance whose activity affects or plays a role in the functioning of the immune system.
IRI: http://purl.obolibrary.org/obo/chebi/Immunosuppressant
An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
IRI: http://purl.obolibrary.org/obo/DOID/InclusionBodyMyositis
A myositis that is characterized by slowly progressive weakness and wasting of both distal and proximal muscles, most apparent in the muscles of the arms and legs that can occur in a sporadic or hereditary forms.
IRI: http://purl.obolibrary.org/obo/DOID/InfectiousDisease
A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/IntegumentarySystem
IRI: http://purl.obolibrary.org/obo/DOID/IntegumentarySystemDisease
A disease of anatomical entity that is located_in the integumentary system comprising the skin and its appendages.
IRI: http://purl.org/sig/ont/fma/Intestine
IRI: http://purl.org/sig/ont/fma/Joint
IRI: http://purl.org/sig/ont/fma/Kidney
IRI: http://purl.org/sig/ont/fma/LacrimalGland
IRI: http://purl.org/sig/ont/fma/Larynx
IRI: http://purl.obolibrary.org/obo/chebi/Laxative
An agent that produces a soft formed stool, and relaxes and loosens the bowels, typically used over a protracted period, to relieve constipation. Compare with cathartic, which is a substance that accelerates defecation. A substances can be both a laxative and a cathartic.
IRI: http://purl.obolibrary.org/obo/DOID/LimitedScleroderma
IRI: http://purl.org/sig/ont/fma/Liver
IRI: http://purl.obolibrary.org/obo/DOID/LocalizedScleroderma
IRI: http://purl.org/sig/ont/fma/Lung
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Lymph
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/LymphaticSystem
IRI: http://purl.org/sig/ont/fma/Lymphnode
IRI: http://purl.obolibrary.org/obo/chebi/MAOI
MonoAmine Oxidase Inhibitor. An EC 1.4.3.* (oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor) inhibitor that interferes with the action of monoamine oxidase (EC 1.4.3.4).
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/MedicalDoctor
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/MedicalPractitioner
IRI: http://sisinflab.poliba.it/swottools/onto/sh#MedullaryEpiduralStimulation
IRI: http://purl.obolibrary.org/obo/DOID/MetabolicDisease
A disease that involving errors in metabolic processes of building or degradation of molecules.
IRI: http://sisinflab.poliba.it/swottools/onto/sh#MildSystemicLupusErythematosus
IRI: http://purl.obolibrary.org/obo/DOID/MixedConnectiveTissueDisease
A collagen disease that is considered an overlap of three diseases, systemic lupus erythematosus, scleroderma, and polymyositis with very high titers of circulating antinuclear antibody to a ribonucleoprotein antigen.
IRI: http://purl.org/sig/ont/fma/Muscle
IRI: http://purl.obolibrary.org/obo/uberon/MuscularSystem
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/MusculoskeletalSystem
IRI: http://purl.obolibrary.org/obo/DOID/MusculoskeletalSystemAutoimmuneDisease
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the musculoskeletal system.
IRI: http://purl.obolibrary.org/obo/DOID/MusculoskeletalSystemDisease
A disease of anatomical entity that occurs in the muscular and/or skeletal system.
IRI: http://purl.obolibrary.org/obo/chebi/NSAID
Non-Steroidal Anti-Inflammatory Drug. An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
IRI: http://purl.org/sig/ont/fma/Nail
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/NervousSystem
IRI: http://purl.obolibrary.org/obo/DOID/NervousSystemDisease
IRI: http://purl.obolibrary.org/obo/chebi/Neuroleptics
Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
IRI: http://purl.obolibrary.org/obo/chebi/OpioidAgent
Any agent that acts on an opioid receptor or affects the life cycle of an opioid transmitter.
IRI: http://purl.obolibrary.org/obo/DOID/OverlapSyndrome
IRI: http://purl.org/sig/ont/fma/Pancreas
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Paramedic
IRI: http://purl.obolibrary.org/obo/DOID/ParasiticInfectiousDisease
A disease by infectious agent that is carried out by a parasite which by definition is a pathogen that simultaneously injures and derives sustenance from its host.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/PeripheralNervousSystem
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/PharmaceuticalProduct
IRI: http://purl.org/sig/ont/fma/Pharynx
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Physiotherapy
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Plasmapheresis
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Poisoning
IRI: http://purl.obolibrary.org/obo/DOID/Polymyositis
IRI: http://purl.obolibrary.org/obo/DOID/PolymyositisDermatomyositis
IRI: http://purl.obolibrary.org/obo/DOID/PrematureMembranesRupture
A female reproductive system disease characterized by rupture of chorioamniotic membranes before 37 weeks of gestation.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Preventive
IRI: http://purl.obolibrary.org/obo/chebi/Psychopharmaceutical
A loosely defined grouping of drugs that have effects on psychological function.
IRI: http://purl.org/sig/ont/fma/Rectum
IRI: http://purl.obolibrary.org/obo/DOID/ReproductiveSystemDisease
A disease of anatomical entity that is located_in reproductive system organs.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/RespiratorySystem
IRI: http://purl.obolibrary.org/obo/DOID/RespiratorySystemDisease
A disease of anatomical entity that located_in the respiratory system which extends from the nasal sinuses to the diaphragm.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Rheumatologist
IRI: http://purl.obolibrary.org/obo/chebi/Salicylates
Any salt or ester arising from reaction of the carboxy group of salicylic acid, or any ester resulting from the condensation of the phenolic hydroxy group of salicylic acid with an organic acid.
IRI: http://purl.org/sig/ont/fma/SalivaryGland
IRI: http://purl.obolibrary.org/obo/DOID/Scleroderma
A rheumatic disease and collagen disease that involves the abnormal growth of connective tissue, which supports the skin and internal organs.
IRI: http://sisinflab.poliba.it/swottools/onto/sh#SevereSystemicLupusErythematosus
IRI: http://purl.obolibrary.org/obo/DOID/SjogrenSyndrome
A hypersensitivity reaction type II disease that involves attack of immune cells which destroy the exocrine glands that produce tears and saliva.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/SkeletalSystem
IRI: http://purl.org/sig/ont/fma/Skin
IRI: http://purl.obolibrary.org/obo/DOID/SkinDisease
An integumentary system disease that is located_in skin.
IRI: http://purl.obolibrary.org/obo/uberon/SkinOfFace
IRI: http://purl.obolibrary.org/obo/uberon/SkinOfLeg
IRI: http://purl.obolibrary.org/obo/uberon/SkinOfLimb
IRI: http://purl.obolibrary.org/obo/uberon/SkinOfManus
IRI: http://purl.obolibrary.org/obo/uberon/SkinOfTrunk
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/SpecializedPhysician
IRI: http://purl.org/sig/ont/fma/Spleen
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Stimulation
IRI: http://purl.org/sig/ont/fma/Stomach
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Surgeon
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/Symptomatic
IRI: http://purl.obolibrary.org/obo/uberon/Synarthrosis
IRI: http://purl.org/sig/ont/fma/SynovialJoint
IRI: http://purl.obolibrary.org/obo/DOID/SystemicLupusErythematosus
A lupus erythematosus that is an inflammation of connective tissue marked by skin rashes, joint pain and swelling, inflammation of the kidneys and inflammation of the tissue surrounding the heart.
IRI: http://purl.obolibrary.org/obo/DOID/SystemicScleroderma
A scleroderma that is characterized by fibrosis (or hardening) of the skin and major organs, as well as vascular alterations, and autoantibodies.
IRI: http://purl.org/sig/ont/fma/Tendon
IRI: http://purl.obolibrary.org/obo/ogms/TherapeuticProcedure
IRI: http://purl.org/sig/ont/fma/Trachea
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Trauma
Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.
IRI: http://purl.obolibrary.org/obo/ogms/Treatment
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Undifferentiated_Connective_Tissue_Disease
IRI: http://purl.org/sig/ont/fma/Ureter
IRI: http://purl.org/sig/ont/fma/Urethra
IRI: http://purl.org/sig/ont/fma/UrinaryBladder
IRI: http://purl.obolibrary.org/obo/DOID/UrinarySystemDisease
A disease of anatomical entity that is located_in kidney, ureter, bladder and urethra.
IRI: http://purl.obolibrary.org/obo/DOID/ViralInfectiousDisease
A disease by infectious agent that results_in infection, has_material_basis_in Viruses.
IRI: http://purl.bioontology.org/ontology/SNOMEDCT/VisualSystem
IRI: http://sisinflab.poliba.it/swottools/onto/sh#affects
IRI: http://sisinflab.poliba.it/swottools/onto/sh#increasedBy
IRI: http://sisinflab.poliba.it/swottools/onto/sh#increases
IRI: http://sisinflab.poliba.it/swottools/onto/sh#reducedBy
IRI: http://sisinflab.poliba.it/swottools/onto/sh#reduces
IRI: http://sisinflab.poliba.it/swottools/onto/sh#seriousEffect
IRI: http://sisinflab.poliba.it/swottools/onto/sh#therapy
IRI: http://sisinflab.poliba.it/swottools/onto/sh#adalimumab
IRI: http://sisinflab.poliba.it/swottools/onto/sh#aspirin
IRI: http://sisinflab.poliba.it/swottools/onto/sh#azathioprine
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Cece_Colvin
IRI: http://sisinflab.poliba.it/swottools/onto/sh#ciclosporin
IRI: http://sisinflab.poliba.it/swottools/onto/sh#cortisone
IRI: http://sisinflab.poliba.it/swottools/onto/sh#cyclophosphamide
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Denny_Duquette
IRI: http://sisinflab.poliba.it/swottools/onto/sh#etanercept
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Henry_Burton
IRI: http://sisinflab.poliba.it/swottools/onto/sh#hydroxychloroquine
IRI: http://sisinflab.poliba.it/swottools/onto/sh#ibuprofen
IRI: http://sisinflab.poliba.it/swottools/onto/sh#infliximab
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Janice_Burke
IRI: http://sisinflab.poliba.it/swottools/onto/sh#John_Doe
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Michael_Ross
IRI: http://sisinflab.poliba.it/swottools/onto/sh#prednisone
IRI: http://sisinflab.poliba.it/swottools/onto/sh#propranolol
IRI: http://sisinflab.poliba.it/swottools/onto/sh#Salvatore_Panda
IRI: http://sisinflab.poliba.it/swottools/onto/sh#aicCode
AIC code: Autorizzazione all’immissione in commercio di un farmaco. Viene concessa dall’AIFA dopo che un gruppo di esperti ne ha valutato la sicurezza e l’efficacia.
IRI: http://sisinflab.poliba.it/swottools/onto/sh#atcCode
ATC Code: Anatomical Therapeutic Chemical Classification System
IRI: http://sisinflab.poliba.it/swottools/onto/sh#disabilityIndex
IRI: http://purl.org/healthcarevocab/v1#PatientAge
IRI: http://purl.org/healthcarevocab/v1#PatientBirthDate
IRI: http://purl.org/healthcarevocab/v1#PatientID
IRI: http://purl.org/healthcarevocab/v1#PatientName
IRI: http://purl.org/healthcarevocab/v1#PatientSex
IRI: http://purl.org/healthcarevocab/v1#PatientWeight
This HTML document was obtained by processing the OWL ontology source code through LODE, Live OWL Documentation Environment, developed by Silvio Peroni.
Angiotensin-converting enzyme Inhibitor. An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1).